A endothelin receptor antagonist (ERA) is a
drug which blocks
endothelin receptors. Two main kinds of ERAs exist:
selective (e.g. sitaxsentan), which affect endothelin A, and
dual ERAs, which affect both endothelin A and B (e.g.
bosentan)